Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D, Bertoli D, Cattaneo C, Almici C, Re A, Belotti A, Borlenghi E, Lanzi G, Archetti S, Verardi R, Brugnoni D, Sciumè M, Daffini R, Roccaro AM, Tucci A, Rossi G. Gramegna D, et al. Among authors: bertoli d. Ann Hematol. 2022 Jun;101(6):1227-1237. doi: 10.1007/s00277-022-04806-x. Epub 2022 Apr 5. Ann Hematol. 2022. PMID: 35380239
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.
Moschetta M, Kawano Y, Sacco A, Belotti A, Ribolla R, Chiarini M, Giustini V, Bertoli D, Sottini A, Valotti M, Ghidini C, Serana F, Malagola M, Imberti L, Russo D, Montanelli A, Rossi G, Reagan MR, Maiso P, Paiva B, Ghobrial IM, Roccaro AM. Moschetta M, et al. Among authors: bertoli d. Curr Osteoporos Rep. 2017 Oct;15(5):499-506. doi: 10.1007/s11914-017-0399-3. Curr Osteoporos Rep. 2017. PMID: 28889371 Review.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Borlenghi E, Cattaneo C, Cerqui E, Archetti S, Bertoli D, Bellotti D, Gramegna D, Soverini G, Oberti M, Schieppati F, Pagani C, Passi A, Sciumé M, Farina M, Carbone C, Crippa C, Dalceggio D, Tucci A, Rossi G. Borlenghi E, et al. Among authors: bertoli d. Hematol Oncol. 2020 Dec;38(5):754-762. doi: 10.1002/hon.2806. Epub 2020 Sep 29. Hematol Oncol. 2020. PMID: 32950042
Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.
Borlenghi E, Cattaneo C, Bertoli D, Cerqui E, Archetti S, Passi A, Oberti M, Zollner T, Giupponi C, Pagani C, Bianchetti N, Bottelli C, Bagnasco S, Sciumè M, Tucci A, Rossi G. Borlenghi E, et al. Among authors: bertoli d. Cancers (Basel). 2022 Sep 28;14(19):4716. doi: 10.3390/cancers14194716. Cancers (Basel). 2022. PMID: 36230640 Free PMC article.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C, Pascale MR, Vitale A, Diral E, Tomelleri A, Galossi E, Falconi G, Bruno A, Crisafulli F, Frassi M, Cattaneo C, Bertoli D, Bernardi M, Condorelli A, Morsia E, Poloni A, Crisà E, Caravelli D, Triggianese P, Brussino L, Battipaglia G, Bindoli S, Sfriso P, Caroni F, Dragani M, Mallegni F, Pilo F, Firinu D, Curti A, Papayannidis C, Olivieri A, Kordasti S, Albano F, Pane F, Musto P, Bocchia M, Lugli E, Breccia M, Frigeni M, Dagna L, Greco R, Franceschini F, Campochiaro C, Cantarini L, Voso MT. Gurnari C, et al. Among authors: bertoli d. Am J Hematol. 2024 Feb;99(2):254-262. doi: 10.1002/ajh.27169. Epub 2023 Dec 18. Am J Hematol. 2024. PMID: 38108611
Long-lasting production of new T and B cells and T-cell repertoire diversity in patients with primary immunodeficiency who had undergone stem cell transplantation: a single-centre experience.
Valotti M, Sottini A, Lanfranchi A, Bolda F, Serana F, Bertoli D, Giustini V, Tessitore MV, Caimi L, Imberti L. Valotti M, et al. Among authors: bertoli d. J Immunol Res. 2014;2014:240453. doi: 10.1155/2014/240453. Epub 2014 Dec 1. J Immunol Res. 2014. PMID: 25756054 Free PMC article.
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients.
Chiarini M, Capra R, Serana F, Bertoli D, Sottini A, Giustini V, Scarpazza C, Rovaris M, Torri Clerici V, Ferraro D, Galgani S, Solaro C, Conti MZ, Visconti A, Imberti L; SURROGATE Study Group. Chiarini M, et al. Among authors: bertoli d. J Transl Med. 2020 Apr 16;18(1):169. doi: 10.1186/s12967-020-02329-5. J Transl Med. 2020. PMID: 32299447 Free PMC article.
139 results